379 related articles for article (PubMed ID: 28476437)
1. Sjogren's syndrome from the perspective of ophthalmology.
Kuklinski E; Asbell PA
Clin Immunol; 2017 Sep; 182():55-61. PubMed ID: 28476437
[TBL] [Abstract][Full Text] [Related]
2. Approaches to the treatment of Sjögren's syndrome.
Fox RI; Michelson P
J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
[TBL] [Abstract][Full Text] [Related]
3. The therapy of Sjogren's syndrome: a review.
Coaccioli S; Giuliani M; Puxeddu A
Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
Ogawa Y
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
[TBL] [Abstract][Full Text] [Related]
6. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Fox RI; Konttinen Y; Fisher A
Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
[TBL] [Abstract][Full Text] [Related]
8. Different perception of dry eye symptoms between patients with and without primary Sjogren's syndrome.
Kim M; Chun YS; Kim KW
Sci Rep; 2022 Feb; 12(1):2172. PubMed ID: 35140286
[TBL] [Abstract][Full Text] [Related]
9. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
Ramos-Casals M; Brito-Zerón P; Bombardieri S; Bootsma H; De Vita S; Dörner T; Fisher BA; Gottenberg JE; Hernandez-Molina G; Kocher A; Kostov B; Kruize AA; Mandl T; Ng WF; Retamozo S; Seror R; Shoenfeld Y; Sisó-Almirall A; Tzioufas AG; Vitali C; Bowman S; Mariette X;
Ann Rheum Dis; 2020 Jan; 79(1):3-18. PubMed ID: 31672775
[TBL] [Abstract][Full Text] [Related]
10. Dry eye in Sjögren's syndrome - characteristics and therapy.
Caban M; Omulecki W; Latecka-Krajewska B
Eur J Ophthalmol; 2022 Nov; 32(6):3174-3184. PubMed ID: 35354331
[TBL] [Abstract][Full Text] [Related]
11. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Al-Hashimi I
Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
[TBL] [Abstract][Full Text] [Related]
15. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
Garcia DM; Reis de Oliveira F; Módulo CM; Faustino J; Barbosa AP; Alves M; Rocha EM
PLoS One; 2018; 13(12):e0208420. PubMed ID: 30507949
[TBL] [Abstract][Full Text] [Related]
16. [The effectiveness of cevimeline hydrochloride on dry cough in Sjögren's syndrome].
Nishinarita M; Hanzawa M; Iikuni N; Ota S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):99-102. PubMed ID: 15164930
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren's Syndrome.
Gao M; Zhao L; Liang R; Zhu Q; Zhao Q; Kong X
Ocul Immunol Inflamm; 2023 Oct; 31(8):1662-1668. PubMed ID: 35914303
[TBL] [Abstract][Full Text] [Related]
18. Ocular Pathophysiology of Sjögren's Syndrome.
Tauqeer Z; Bunya VY; Macchi I; Massaro-Giordano M
Ocul Immunol Inflamm; 2021 May; 29(4):796-802. PubMed ID: 33830848
[TBL] [Abstract][Full Text] [Related]
19. Reflex tearing in dry eye not associated with Sjögren's syndrome.
Tsubota K
Adv Exp Med Biol; 1998; 438():903-7. PubMed ID: 9634986
[No Abstract] [Full Text] [Related]
20. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
